Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 April 1999

Effects of baclophen on the growth of 16/C transplantable mouse mammary adenocarcinoma (in vivo)

Maria Mazurkiewicz, Joanna Wietrzyk, Adam Opolski, Czesław Radzikowski, Zdzisław Kleinrok

Med Sci Monit 1999; 5(3): BR434-439 :: ID: 504762

Abstract

Described here is the protective effect of GABA receptor agonists (baclophen and muscimol) on the development of chemically induced digestive tract rodent tumors. The aim of this study was to evaluate the antitumor effect of baclophen administration on the growth of a transplantable mouse mammary cancer 16/C. All mice (C3H/W) were inoculated subcutaneously with 16/C tumor cells into the right flank region. Experimental group mice received baclophen in different doses (10mg/kg/day and 20mg/kg/day) and two different schedules. Control mice received a 0.9% NaCl solution only. Observations were carried out for a period of 22 days and tumor measurements were performed. The tumor volume was calculated by means of the formula (a2 x b)/2. Statistical analysis was performed by means of the t-Student's test. The difference was considered as significant when the p value was less than 0.05. We demonstrated an inhibitory effect of baclophen administration on the growth of transplantable mouse mammary cancer. This effect was dependent both on the dose and schedule of baclophen administration. Twenty mg/kg/day beginning 6 days before tumor implantation and ending on the 19th dayappeared to be the most effective treatment schedule. The mechanism of baclophen's antitumor effect remains unclear. We may consider baclophen's known effect on the hormonal system. It is also known that GABA and its agonists may influence some stages of neuroendocrine regulation. Moreover, there exists strong evidence that the GABA-ergic system is regulated by hormones. It is known that the mammary gland is affected by hormones, and breast cancer is classified as a hormone-dependent tumor.

Keywords: GAD, GABA, Baclophen, treatment, Adenocarcinoma

Add Comment 0 Comments

525 2

Editorial

01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209

0:00

In Press

01 Jun 2023 : Clinical Research  

Root Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940472  

01 Jun 2023 : Clinical Research  

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease

Med Sci Monit In Press; DOI: 10.12659/MSM.940873  

01 Jun 2023 : Clinical Research  

Effectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...

Med Sci Monit In Press; DOI: 10.12659/MSM.940187  

01 Jun 2023 : Clinical Research  

Influence of Insulin Resistance on Diabetes Nephropathy

Med Sci Monit In Press; DOI: 10.12659/MSM.939482  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750